Trifluoroacetic acid → HCID 11542145, compound
Reaction equation
[O:1]=[C:2]1[N:8]([CH:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C@@H:18]([C:32](O)=[O:33])[CH2:19][C:20]3[CH:30]=[C:29]([CH3:31])[C:23]4[N:24]([CH3:28])[C:25](=[O:27])[O:26][C:22]=4[CH:21]=3)=[O:16])[CH2:11][CH2:10]2)[CH2:7][CH2:6][C:5]2[CH:35]=[CH:36][CH:37]=[CH:38][C:4]=2[NH:3]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.C(N(CC)CC)C.[CH3:68][C:69]1([NH:81]C(=O)OC(C)(C)C)[CH2:74][CH2:73][N:72]([CH:75]2[CH2:80][CH2:79][NH:78][CH2:77][CH2:76]2)[CH2:71][CH2:70]1.C(O)(C(F)(F)F)=O>CN(C=O)C.C(Cl)Cl>[O:1]=[C:2]1[N:8]([CH:9]2[CH2:14][CH2:13][N:12]([C:15]([O:17][C@H:18]([CH2:19][C:20]3[CH:30]=[C:29]([CH3:31])[C:23]4[N:24]([CH3:28])[C:25](=[O:27])[O:26][C:22]=4[CH:21]=3)[C:32]([N:78]3[CH2:79][CH2:80][CH:75]([N:72]4[CH2:73][CH2:74][C:69]([NH2:81])([CH3:68])[CH2:70][CH2:71]4)[CH2:76][CH2:77]3)=[O:33])=[O:16])[CH2:11][CH2:10]2)[CH2:7][CH2:6][C:5]2[CH:35]=[CH:36][CH:37]=[CH:38][C:4]=2[NH:3]1Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 80 mg (0.15 mmol) (R)-1-carboxy-2-(3,4-dimethyl-2-oxo-2,3-dihydrobenz-oxazol-6-yl)-ethyl 4-(2-oxo-1,2,4,5,-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, 58 mg (0.18 mmol) TBTU, 140 μL (1.00 mmol) triethylamine and 59 mg (0.16 mmol) tert.-butyl (4-methyl-[1,4′]bipiperidinyl-4-yl)-carbamate in 1.8 mL DMF were stirred overnight at RT. The reaction mixture was purified by HPLC, the fractions containing the product were combined and lyophilised. The residue obtained was dissolved in 4 mL DCM, combined with 0.5 mL TFA and the reaction solution was stirred for 5 h at RT. The DCM was left to evaporate off overnight, the residue was combined with 2 mL 15% K2CO3 solution and extracted twice with 2 mL DCM. After the solvent had been eliminated the residue was taken up in 1 mL DMF and purified by HPLC. The fractions containing the product were combined and lyophilised.
Workup
- customThe reaction mixture was purified by HPLC
- additionthe fractions containing the product
- customThe residue obtained
- customto evaporate off overnight
- extractionextracted twice with 2 mL DCM
- custompurified by HPLC
- additionThe fractions containing the product
Sources & evidence
- ORD record
- ord-8c84d6185b9f42d9a440e204f3807606
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07696195B2
Reaction notes
Loading…